ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 169 filers reported holding ZOGENIX INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,459,000 | -33.6% | 415,982 | 0.0% | 0.19% | -38.6% |
| Q2 2020 | $11,236,000 | +13.6% | 415,982 | +4.0% | 0.31% | -24.7% |
| Q1 2020 | $9,892,000 | -24.1% | 400,000 | +60.0% | 0.41% | -0.7% |
| Q4 2019 | $13,033,000 | +30.2% | 250,000 | 0.0% | 0.41% | +3.3% |
| Q3 2019 | $10,010,000 | -10.8% | 250,000 | +6.4% | 0.40% | -1.7% |
| Q2 2019 | $11,228,000 | -13.1% | 235,000 | 0.0% | 0.41% | -18.5% |
| Q1 2019 | $12,927,000 | +50.9% | 235,000 | 0.0% | 0.50% | +23.3% |
| Q4 2018 | $8,568,000 | -26.5% | 235,000 | 0.0% | 0.40% | -4.3% |
| Q3 2018 | $11,656,000 | +16.7% | 235,000 | +4.0% | 0.42% | +9.9% |
| Q2 2018 | $9,989,000 | +10.6% | 226,000 | +0.2% | 0.38% | -0.3% |
| Q1 2018 | $9,031,000 | 0.0% | 225,500 | 0.0% | 0.38% | -6.1% |
| Q4 2017 | $9,031,000 | +157.7% | 225,500 | +125.5% | 0.41% | +153.1% |
| Q3 2017 | $3,505,000 | – | 100,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 971,875 | $24,034,000 | 14.58% |
| Eversept Partners, LP | 2,013,467 | $49,793,039 | 12.38% |
| Pinz Capital Management, LP | 98,800 | $2,443,000 | 6.40% |
| RA Capital Management | 5,275,538 | $130,464,000 | 4.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,797 | $6,955,000 | 3.17% |
| Granite Point Capital Management, L.P. | 203,462 | $5,032,000 | 2.84% |
| Avoro Capital Advisors LLC | 2,800,000 | $69,244,000 | 2.34% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,029,699 | $25,464,000 | 2.33% |
| Eventide Asset Management | 2,841,300 | $70,265,000 | 2.28% |
| Perceptive Advisors | 3,452,921 | $85,390,000 | 2.22% |